Moreover, since EphA2/TGFβ/COX2 signaling in cancer cells is known to suppress the number of infiltrating T lymphocytes in pancreatic cancer [49], it may be possible that exosome-mediated EphA2 delivery between cancer cells further concurrently influences on cancer microenvironment. This evidence concerns the gene EPHA2 and pancreatic neoplasm.